SI2044020T1 - CRYSTALLINE FORMS OF 4- ?á2- (4-METHYLPHENYLSULFANYL) -PHENYL?åPIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAIN - Google Patents
CRYSTALLINE FORMS OF 4- ?á2- (4-METHYLPHENYLSULFANYL) -PHENYL?åPIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAINInfo
- Publication number
- SI2044020T1 SI2044020T1 SI200730594T SI200730594T SI2044020T1 SI 2044020 T1 SI2044020 T1 SI 2044020T1 SI 200730594 T SI200730594 T SI 200730594T SI 200730594 T SI200730594 T SI 200730594T SI 2044020 T1 SI2044020 T1 SI 2044020T1
- Authority
- SI
- Slovenia
- Prior art keywords
- åpiperidine
- methylphenylsulfanyl
- phenyl
- treatment
- neuropathic pain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/08—Malonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/12—Glutaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/08—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80500906P | 2006-06-16 | 2006-06-16 | |
DKPA200600816 | 2006-06-16 | ||
DKPA200700423 | 2007-03-20 | ||
PCT/DK2007/050076 WO2007144006A1 (en) | 2006-06-16 | 2007-06-15 | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
EP07764496A EP2044020B1 (en) | 2006-06-16 | 2007-06-15 | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2044020T1 true SI2044020T1 (en) | 2011-06-30 |
Family
ID=39722478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200730594T SI2044020T1 (en) | 2006-06-16 | 2007-06-15 | CRYSTALLINE FORMS OF 4- ?á2- (4-METHYLPHENYLSULFANYL) -PHENYL?åPIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAIN |
Country Status (15)
Country | Link |
---|---|
JP (1) | JP2014098017A (en) |
KR (1) | KR101472595B1 (en) |
AR (1) | AR061480A1 (en) |
AT (1) | ATE508115T1 (en) |
BR (1) | BRPI0712758A2 (en) |
CA (1) | CA2784304A1 (en) |
DE (1) | DE602007014372D1 (en) |
DK (1) | DK2044020T3 (en) |
MY (1) | MY150698A (en) |
NZ (1) | NZ572856A (en) |
PT (1) | PT2044020E (en) |
RS (1) | RS51687B (en) |
SI (1) | SI2044020T1 (en) |
TN (1) | TNSN08461A1 (en) |
TW (1) | TWI444365B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101972931B1 (en) | 2017-10-19 | 2019-04-26 | 재단법인대구경북과학기술원 | Balloon type ecog measuring device and its manufacturing method |
CN116930385B (en) * | 2023-08-08 | 2024-02-20 | 北京爱思益普生物科技股份有限公司 | Method for measuring concentration of compound in high-salt-concentration preparation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA81749C2 (en) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Derivated of phenylpiperazine as serotonin reuptake inhibitorS |
PL2044020T3 (en) * | 2006-06-16 | 2011-09-30 | H Lundbeck As | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
-
2007
- 2007-06-15 AT AT07764496T patent/ATE508115T1/en active
- 2007-06-15 PT PT07764496T patent/PT2044020E/en unknown
- 2007-06-15 MY MYPI20084894 patent/MY150698A/en unknown
- 2007-06-15 SI SI200730594T patent/SI2044020T1/en unknown
- 2007-06-15 DK DK07764496.1T patent/DK2044020T3/en active
- 2007-06-15 BR BRPI0712758-8A patent/BRPI0712758A2/en not_active IP Right Cessation
- 2007-06-15 NZ NZ572856A patent/NZ572856A/en not_active IP Right Cessation
- 2007-06-15 CA CA2784304A patent/CA2784304A1/en not_active Abandoned
- 2007-06-15 AR ARP070102640A patent/AR061480A1/en unknown
- 2007-06-15 RS RS20110223A patent/RS51687B/en unknown
- 2007-06-15 DE DE602007014372T patent/DE602007014372D1/en active Active
- 2007-06-20 TW TW096121999A patent/TWI444365B/en not_active IP Right Cessation
-
2008
- 2008-11-17 TN TNP2008000461A patent/TNSN08461A1/en unknown
- 2008-12-11 KR KR1020087030260A patent/KR101472595B1/en not_active IP Right Cessation
-
2014
- 2014-02-03 JP JP2014018411A patent/JP2014098017A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DK2044020T3 (en) | 2011-08-15 |
ATE508115T1 (en) | 2011-05-15 |
DE602007014372D1 (en) | 2011-06-16 |
TNSN08461A1 (en) | 2010-04-14 |
AR061480A1 (en) | 2008-08-27 |
JP2014098017A (en) | 2014-05-29 |
KR20090018630A (en) | 2009-02-20 |
TWI444365B (en) | 2014-07-11 |
MY150698A (en) | 2014-02-28 |
CA2784304A1 (en) | 2007-12-21 |
NZ572856A (en) | 2012-02-24 |
PT2044020E (en) | 2011-05-12 |
RS51687B (en) | 2011-10-31 |
TW200817329A (en) | 2008-04-16 |
KR101472595B1 (en) | 2014-12-15 |
BRPI0712758A2 (en) | 2012-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1134287A1 (en) | Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain | |
HK1220705A1 (en) | Treatment of acute lymphoblastic leukemia | |
EP1976377A4 (en) | Compounds for the treatment of metabolic disorders | |
EP1983972A4 (en) | Compounds for the treatment of metabolic disorders | |
ZA200808963B (en) | Compounds for the treatment of metabolic disorders | |
IL194189A0 (en) | Combination treatment of metabolic disorders | |
ZA200805645B (en) | Compounds for the treatment of metabolic disorders | |
HK1125831A1 (en) | Fat accumulation inhibitor for the treatment of metabolic syndrome | |
IL202639A0 (en) | Treatment of neuropathic pain | |
IL192851A0 (en) | Compounds for the treatment of metabolic disorders | |
SI2044020T1 (en) | CRYSTALLINE FORMS OF 4- ?á2- (4-METHYLPHENYLSULFANYL) -PHENYL?åPIPERIDINE WITH COMBINED SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITION FOR THE TREATMENT OF NEUROPATHIC PAIN | |
IL195392A0 (en) | Compounds for the treatment of metabolic disorders | |
GB0604782D0 (en) | Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders | |
ZA200809917B (en) | Crystalline forms of 4- [2-(4-Methylphenylsulfanyl) - Phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain | |
IL198999A0 (en) | Compounds with a combination of cannabinobi-cb1 antagonism and serotonin reuptake inhibition | |
EP2240024A4 (en) | Compounds for the treatment of metabolic disorders | |
GB0604783D0 (en) | Use of substituted oxime compounds for the treatment of food related disorders | |
IL192982A0 (en) | Compounds for the treatment of metabolic disorders |